Acute Lymphoblastic Leukaemia

UKALL 14

A randomized trial for adults with newly diagnosed acute lymphoblastic leukaemia.

For precursor-B lineage ALL, the main aim is to determine if the addition of Rituximab to standard induction chemotherapy results in improved EFS.

For T lineage ALL, the main aim is to determine if the addition of nelarabine following standard induction therapy improves outcomes.

UKALL2011

United Kingdom National Randomised Trial For Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoma 2011

UKALL60+

 

A Phase 2 study for older adults with Acute Lymphoblastic Leukaemia